Other research
.jpg)
The Leuven Diabetes Lab has access to cutting-edge flow cytometry and single-cell technologies through grant-funded infrastructure, with support from Dr. Chantal Mathieu’s strategic leadership.
Other projects
1/1/2023
-
12/31/2024
Unique IsoPlexis technology for multiplexed single cell functional profiling
Promotors:
Chantal Mathieu
5/1/2022
-
4/30/2026
Next-generation, multi-technology immune-monitoring and easy-access spectral flow cytometry
Promotors:
Chantal Mathieu
5/1/2020
-
4/30/2024
Translational research-oriented technology platform for single cell analysis
Promotors:
Chantal Mathieu
5/1/2018
-
4/30/2022
Mass cytometry by time-of-flight: next-generation flow cytometry for multiplexed single cell analysis.
Promotors:
Chantal Mathieu
10/1/2016
-
9/30/2018
Histology: a vital tool for endocrine and metabolic research
Promotors:
Chantal Mathieu
7/1/2016
-
12/31/2025
Continued provision of an affordable medium-parametric cell analysis solution at the KU Leuven FACS Core
Promotors:
Chantal Mathieu
6/26/2014
-
12/25/2018
Automated platform for high-throughput microbiome analysis
Promotors:
Chantal Mathieu
Support us
Choose to make a direct impact by contributing to a specific research project or by supporting the overarching goals of the Hippo & Friends Type 1 Diabetes Fund.
By donating today, you enable early-career scientists to pursue groundbreaking research aimed at preventing and curing type 1 diabetes.
Every contribution moves us one step closer to breakthroughs that matter.